Malignant Ascites Alfapump Study

ABSTRACT: ProMAS is a prospective post-marketing, single-arm study to assess performance and safety of the Alfapump system in the treatment of patients with malignant ascites. The study aims to enroll 40 patients in up to 8 sites in Europe.

DISEASE(S): Ascites,Malignant Ascites

PROVIDER: 2315279 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR